(3-Chloro-4-(ethoxycarbonyl)phenyl)boronic acid, 95.0%, 1g

5-Ethynyl-2-fluoroaniline, 97%, 1g

2'-Deoxycytidine hydrochloride, 99.0%, 5g

1-Butylnaphthalene, 95.00%, 1g

Fmoc-(R)-3-Amino-4-(1-naphthyl)-butyric acid, 97%, 250mg

4-Chloro-3-methyl-1H-pyrazole, 95.0%, 5g

(S)-(-)-2-Acetoxypropionyl Chloride>97.0%(GC)(T)5g

2-Chloro-6-(trifluoromethyl)benzyl alcohol, 98.0%, 1g

1,3,2-Dioxaborolane, 2-[3-[(2,6-difluorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-, 95%, 100mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 100 µl, 1710 RN, 1 piece

methyl 4-hydroxy-3-methoxy-5-nitrobenzoate, 95.0%, 10g

1-(4-Methoxyphenyl)ethynyl-4-pentylbenzene>98.0%(GC)5g

Blotting Papers ROTILABO® Thickness 0,17 mm, 13 x 10 cm, 100 Piece(s)